SLS
SLS
US81642T2096
SELLAS Life Sciences Group, Inc
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.35B EUR
2.98B EUR
767.04M EUR
577.2M EUR
Enterprise Value
2.14B EUR
2.84B EUR
660.81M EUR
506.41M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-116.5x
--
--
--
Price to Sales
--
--
--
--
Price to Book
17.08x
21.65x
7.14x
8.14x
EV/Revenue
--
--
--
--
EV/EBITDA
--
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-0.7%
-0.95%
-3.67%
-3.35%
ende